In the LEADER trial evaluating liraglutide, patients experienced a mean heart rate increase of approximately 3 beats per minute compared to placebo over the study duration
Oliveira, Juan Pablo Arab, Marco Arrese Nature Reviews Gastroenterology & Hepatology .2026;[Epub] CrossRef Alcohol involvement may modify the association between previous hepatitis B virus infection and hepatocellular carcinoma risk in steatotic liver disease Naohiro Yasuura, Goki Suda, Masatsugu Ohara, Daisuke Yokoyama, Takatsugu Tanaka, Akimitsu Meno, Takuya Sho, Risako Kohya, Ruixin Deng, Qingjie Fu, Zijian Yang, Osamu Maehara, Shunsuke Ohnishi, Takashi Kitagataya, Naoki Kawagishi, Masato Nakai, Tatsuhiko K Journal of Gastroenterology .2026;[Epub] CrossRef The changing epidemiology of primary liver cancer in the 21st century Shahid A
The weight loss was higher on higher doses, and hence, there were more gallbladder-related events
Novo officially sued Hims on Monday, accusing the firm of infringing patents will all forms of the compounded semaglutide it sells including those of the injectable Wegovy and diabetes medicine Ozempic
By acting on brain centers that indicate fullness, Ozempic suppresses appetite and can reduce calories without intentional dieting